Primary Health Care
(ASX:PRY) has confirmed its FY2017 underlying NPTA guidance will be $92 million, which is at the lower end of its previously advised range.
The diagnostic centre company says a decline in medical centres is expected to be partially offset by strong performance in imaging and a modest increase in pathology.
Primary Health Care expects to book a non-cash impairment charge of about $575 million.
Meantime, the company expects its EBIT for FY17 will fall from the prior year (FY16 $72 million) to about $50 million.
Shares in Primary Health Care
(ASX:PRY) are trading are trading 1.67 per cent lower to $3.54.
